WOONSOCKET, R.I., Oct. 1 /PRNewswire/ -- In just 21 days, CVS/pharmacy's ninth annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS) brought in $4.1 million. The funds raised by the campaign will be donated to the Boston-based ALS Therapy Alliance (ATA) to support the funding of new clinical research aimed at developing new therapies for ALS patients and focused on the ultimate goal of finding a cure for ALS. This donation brings the total amount raised by CVS/pharmacy colleagues and customers for ALS research over the last nine years to more than $23 million.
For people like Treg Charlton, a 44-year-old CVS Caremark colleague who was diagnosed with ALS in March, every single $1 donation for ALS research means getting one step closer to finding a treatment or cure for this devastating disease.
Charlton, a husband and father of two young daughters, decided shortly after being diagnosed that he wasn't going to sit on the sidelines while ALS began causing damage to his body. He served as this year's honorary co-chair of the CVS/pharmacy Researching a Cure campaign and plans to stay active in advocating for funding for ALS research.
"It's the challenge of a lifetime, but also a tremendous opportunity to socialize the importance of pushing forward with ALS research to finally discover a cure for it, to deal with the disease in a positive manner and to share my love of life and my optimism for finding a cure, with others," Charlton said.
ALS, or amyotrophic lateral sclerosis, is a disorder in which there is progressive degeneration of motor nerves in the brain and spinal cord leading to paralysis and death, typically within three to five years. There is no known cause or cure for ALS, which affects 25,000 Americans, with 5,000 new cases dia
Copyright©2010 PR Newswire.
All rights reserved